Neuland Laboratories Anno IPO
Cos'è Anno IPO di Neuland Laboratories?
Anno IPO di Neuland Laboratories Limited è 2000
Qual è la definizione di Anno IPO?
L'offerta pubblica iniziale è un tipo di offerta pubblica in cui le azioni di una società di solito sono vendute a investitori istituzionali che, a loro volta, vendono al pubblico in generale, su una borsa valori, per la prima volta.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Anno IPO di aziende nel Health Care settore su BSE rispetto a Neuland Laboratories
Cosa fa Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Aziende con anno ipo simili a Neuland Laboratories
- Arq ha Anno IPO di 1999
- TasFoods ha Anno IPO di 1999
- hopTo ha Anno IPO di 1999
- aap Implantate AG ha Anno IPO di 1999
- Invigor ha Anno IPO di 1999
- Encavis AG ha Anno IPO di 1999
- Neuland Laboratories ha Anno IPO di 2000
- SSR Mining Inc ha Anno IPO di 2001
- Bread Inc ha Anno IPO di 2001
- Exact Sciences ha Anno IPO di 2001
- Cross Country Healthcares ha Anno IPO di 2001
- Friedman Industries ha Anno IPO di 2001
- Chevron ha Anno IPO di 2001